{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:45:54Z","timestamp":1760384754189},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":9245,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1982,5]]},"abstract":"<jats:p>The main aim of this study was to test the effect of the triazolo\u2010benzodiazepine, estazolam, on auditory hallucinations. Fifty\u2010eight patients (28 male, 30 female) with auditory hallucinosis that had responded poorly to neuroleptics alone, were included; most patients were chronic schizophrenics, and most patients were maintained on previous neuroleptic treatment during the trial. Each patient was treated for three consecutive 3\u2010week periods, and randomly allocated to receive estazolam (1 + 1 + 4 mg) either in the first and third, or in the second period. Similar\u2010looking placebo tablets were given in the control periods. There were seven dropouts, three of them due to somnolence on estazolam.<\/jats:p><jats:p>In both treatment groups there was a significant (but not significantly different) improvement during the first 3\u2010week period, with regard to both global clinical state and auditory hallucinations. During the second and third periods, however, the two groups differed significantly, in that improvement of global state and hallucinosis was seen on estazolam, and deterioration on placebo. It is concluded that estazolam (as an addition to neuroleptics) had a significantly better effect than placebo on the global clinical state, on the frequency of, and attitude towards the hallucinations, and also on the single symptoms \u201cCompulsive thoughts\u201d and \u201cVisual hallucinations\u201d (items in the Comprehensive Psychopathological Rating Scale). There were few side effects except drowsiness.<\/jats:p><jats:p>Possible pharmacokinetic and pharmacodynamic interactions between benzodiazepines and neuroleptics are discussed briefly.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1982.tb00855.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:09:15Z","timestamp":1187863755000},"page":"339-354","source":"Crossref","is-referenced-by-count":41,"title":["Effect of the benzodiazepine derivative estazolam in patients with auditory hallucinations"],"prefix":"10.1111","volume":"65","author":[{"given":"O.","family":"Lingj\u00e6rde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.2307\/3001775"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433257"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.118.6.548"},{"key":"e_1_2_1_5_1","first-page":"767","article-title":"The therapeutic effect of lorazepam in psychotic patients treated with haloperidol: a double\u2010blind study","volume":"14","author":"Guz I.","year":"1972","journal-title":"Curr. ther. Res"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.3.231"},{"key":"e_1_2_1_7_1","first-page":"173","article-title":"A reference study of ataraxics","volume":"2","author":"Hankoff L. D.","year":"1961","journal-title":"A two-week double-blind outpatient evaluation. J. new Drugs"},{"key":"e_1_2_1_8_1","first-page":"171","article-title":"Comparative effect of fluphenazine, fluphenazine\u2010chlordiazepoxide and fluphenazine\u2010imipramine","volume":"31","author":"Hanlon T. E.","year":"1970","journal-title":"Dis. nerv. Syst"},{"key":"e_1_2_1_9_1","first-page":"104","article-title":"Combined drug treatment of newly hospitalized, acutely ill psychiatric patients","volume":"30","author":"Hanlon T. E.","year":"1969","journal-title":"Dis. nerv. Syst"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(68)80059-8"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00692778"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760280044004"},{"key":"e_1_2_1_13_1","unstructured":"Lingj\u0153rde O.(1982):Benzodiazepines in the treatment of schizophrenia (in press)."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/08039487809106569"},{"key":"e_1_2_1_15_1","first-page":"505","article-title":"Antipsychotic effect of diazepam when given in addition to neuroleptics in chronic psychotic patients: A double\u2010blind clinical trial","volume":"26","author":"Lingj\u0153rde O.","year":"1979","journal-title":"Curr. ther. Res"},{"key":"e_1_2_1_16_1","first-page":"164","article-title":"Comparison of diazepam, chlorprothixene and chlorpromazine in chronic schizophrenic patients","volume":"25","author":"Maculans G. A.","year":"1964","journal-title":"Dis. nerv. Syst"},{"key":"e_1_2_1_17_1","first-page":"117","article-title":"Chlorpromazine \u2013 chlordiazepoxide and chlorpromazine\u2010imipramine treatment of newly hospitalized, acutely ill psychiatric patients","volume":"8","author":"Michaux M. H.","year":"1966","journal-title":"Curr. ther. Res"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.21.497"},{"key":"e_1_2_1_19_1","first-page":"797","article-title":"Klinische Erfahrungen mit dem Benzodiazepinderivat Valium, einem neuen Psychopharmakon","volume":"93","author":"P\u00f6ldinger W.","year":"1963","journal-title":"Schweiz. med. Wschr"},{"key":"e_1_2_1_20_1","first-page":"441","article-title":"Therapeutic effects of diazepam in psychotics","volume":"8","author":"Vinar O.","year":"1966","journal-title":"Activ. nerv. super"},{"issue":"271","key":"e_1_2_1_21_1","article-title":"The CPRS. Development and applications of a psychiatric rating scale","author":"\u00c5sberg M.","year":"1978","journal-title":"Acta psychiat. scand."},{"key":"e_1_2_1_22_1","unstructured":"National Institute of Mental Health(1973):The documentation of clinical psychotropic drug trials. DHEW Publication No. (HSM)73\u20139038."}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1982.tb00855.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1982.tb00855.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:44:46Z","timestamp":1699461886000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1982.tb00855.x"}},"subtitle":["A MULTICENTRE DOUBLE\u2010BLIND, CROSS\u2010OVER STUDY"],"short-title":[],"issued":{"date-parts":[[1982,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,5]]}},"alternative-id":["10.1111\/j.1600-0447.1982.tb00855.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1982.tb00855.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,5]]}}}